Literature DB >> 16650044

ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population.

E Noguchi1, Y Ohtsuki, K Tokunaga, M Yamaoka-Sageshima, K Ichikawa, T Aoki, M Shibasaki, T Arinami.   

Abstract

BACKGROUND: Asthma is the most common chronic disorder in childhood, and asthma exacerbation is an important cause of childhood morbidity and hospitalization. Asthma is believed to be a complex disorder involving genetic and environmental factors, and several asthma susceptibility loci have been identified through genome-wide screening. A disintegrin and metalloprotease 33 (ADAM33) was the first asthma susceptibility gene to be discovered by positional cloning in 2002.
OBJECTIVE: The aim of the present study was to investigate whether single-nucleotide polymorphisms (SNPs) in ADAM33 are associated with childhood asthma in the Japanese population.
METHODS: Twenty-three ADAM33 SNPs were genotyped by fluorescence correlation spectroscopy with the use of DNA from 155 families (538 members) identified through children with atopic asthma. The transmission disequilibrium test (TDT) was performed for family-based association study.
RESULTS: TDT revealed that minor alleles of S+1, ST+4, and T2 SNPs were over-transmitted to asthma-affected offspring (P<0.05). According to the haplotype TDT, no haplotype of ADAM33 was transmitted preferentially to asthmatic offspring.
CONCLUSION: Our results confirm the involvement of ADAM33 in the development of childhood asthma among the Japanese.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650044     DOI: 10.1111/j.1365-2222.2006.02471.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  24 in total

1.  Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China.

Authors:  Jinling Xiao; Jianyu Han; Xinyan Wang; Demi Hua; Dongju Su; Yongxia Bao; Fuzhen Lv
Journal:  Mol Biol Rep       Date:  2010-12-15       Impact factor: 2.316

2.  ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Authors:  Takuro Sakagami; Nobuyoshi Jinnai; Toshiaki Nakajima; Takashi Sekigawa; Takashi Hasegawa; Eiichi Suzuki; Ituro Inoue; Fumitake Gejyo
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

3.  Association of ADAM33 gene polymorphisms with adult-onset asthma and its severity in an Indian adult population.

Authors:  Priya Tripathi; Shally Awasthi; Rajendra Prasad; Nuzhat Husain; Subramaniam Ganesh
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

4.  Association of IL-4 and ADAM33 gene polymorphisms with asthma in an Indian population.

Authors:  Mahdi Bijanzadeh; Nallur B Ramachandra; P A Mahesh; R Savitha Mysore; Pradeep Kumar; B S Manjunath; B S Jayaraj
Journal:  Lung       Date:  2010-06-04       Impact factor: 2.584

5.  Associations of genetic variants in ADAM33 and TGF-β1 genes with childhood asthma risk.

Authors:  Hongbin Li; Yuchun Li; Mingwu Zhang; Guangchui Xu; Xianjun Feng; Jingzhuan Xi; Bing Zhao
Journal:  Biomed Rep       Date:  2014-05-19

6.  Association of a disintegrin and metalloprotease 33 gene polymorphisms with asthma.

Authors:  Nigela Yilihamu; Qimangul Wushouer; Kadirya Arkin; Hu Xin; Umesh Yadav
Journal:  Mol Clin Oncol       Date:  2014-07-09

7.  Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study.

Authors:  Jason Yongha Kim; Jeong Hyun Kim; Tae Joon Park; Joon Seol Bae; Jin Sol Lee; Charisse Flerida Pasaje; Byung Lae Park; Hyun Sub Cheong; Jong-Sook Park; Sung-Woo Park; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  BMC Pulm Med       Date:  2010-06-01       Impact factor: 3.317

8.  A Six-SNP haplotype of ADAM33 is associated with asthma in a population of Cartagena, Colombia.

Authors:  Candelaria I Vergara; Nathalie Acevedo; Silvia Jiménez; Beatriz Martínez; Dilia Mercado; Leonor Gusmão; Kathleen C Barnes; Luis Caraballo
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

Review 9.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

Review 10.  Role of ADAM and ADAMTS metalloproteinases in airway diseases.

Authors:  Genevieve Paulissen; Natacha Rocks; Maud M Gueders; Celine Crahay; Florence Quesada-Calvo; Sandrine Bekaert; Jonathan Hacha; Mehdi El Hour; Jean-Michel Foidart; Agnes Noel; Didier D Cataldo
Journal:  Respir Res       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.